Related Experiment Videos
Lithium prophylaxis and the kidney
Insights
Lithium treatment for bipolar disorder can cause polyuria, a frequent side effect. Polypharmacy and longer lithium exposure increase this risk, potentially indicating kidney issues.
Area of Science:
- Nephrology
- Psychiatry
- Pharmacology
Background:
- Lithium is a common treatment for bipolar disorder.
- Side effects of lithium therapy require careful monitoring.
- Polyuria is a known, but not fully understood, side effect of lithium.
Purpose of the Study:
- To investigate the incidence and predictors of polyuria in patients on long-term lithium therapy.
- To explore the relationship between polypharmacy and the development of polyuria.
- To identify factors associated with the onset of polyuria as a potential indicator of renal dysfunction.
Main Methods:
- Retrospective review of 44 patients under 55 with bipolar disorder on lithium for ≥6 months.
- Systematic collection of demographic, clinical side-effect, and renal function laboratory data.
- Comparison of polyuria prevalence between patients on lithium alone versus those on lithium plus other psychotropic medications.
Main Results:
- Polyuria was the earliest and most frequent side effect observed.
- Patients on combined psychotropic and lithium therapy showed a significantly higher prevalence of polyuria.
- Onset of polyuria correlated with treatment duration and patient age at therapy initiation.
Conclusions:
- Polypharmacy, duration of lithium exposure, and patient age are predictors of delayed polyuria.
- The development of polyuria may be a symptom of interstitial nephritis.
- These findings highlight the need for monitoring renal function in patients on long-term lithium therapy, especially those with polypharmacy.
Abstract:
We reviewed the records of 44 patients under age 55 with bipolar affective disorder, who were without known systemic illness and receiving lithium prophylactically for a minimum of 6 months. We systematically collected all demographic, family history, and clinical side-effect data. In addition, laboratory results of renal function were compiled. Polyuria was the earliest and most frequent side effect of lithium therapy. Patients receiving other psychotropic medication, plus lithium, showed a significant increased prevalence of polyuria particularly after 3 months of exposure to medication, as compared to patients receiving lithium alone. The onset of polyuria was correlated with duration of lithium treatment and patient's age at initiation of therapy. Our data suggest that polypharmacy, duration of exposure to lithium ion and patient age each predict the development of delayed polyuria, a symptom consistent with interstitial nephritis.